Los Angeles Capital Management LLC / BMRN
Los Angeles Capital Management LLC’s Biomarin Pharmaceutical Inc Position
Does Los Angeles Capital Management LLC own Biomarin Pharmaceutical Inc (BMRN)? Yes — 407.4K shares worth $23M (+0.09% of its 13F portfolio) as of Q1 2026, down from 1.11M shares the prior filed quarter.
Position Value
$23M
Q1 2026
Shares
407.4K
% of Portfolio
+0.09%
Quarters Held
16
currently held
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 407.4K | $23M | +0.09% |
| Q4 2025 | 1.11M | $58M | +0.20% |
| Q3 2025 | 1.33M | $72M | +0.24% |
| Q2 2025 | 278.2K | $15M | +0.06% |
| Q1 2025 | 141.1K | $10M | +0.04% |
| Q4 2024 | 38.5K | $3M | +0.01% |
| Q3 2024 | 10.1K | $709,788 | 0.00% |
| Q4 2023 | 6.9K | $666,359 | 0.00% |
| Q2 2023 | 62.1K | $5M | +0.02% |
| Q1 2023 | 75.7K | $7M | +0.03% |
| Q4 2022 | 76.9K | $8M | +0.04% |
| Q2 2020 | 13.6K | $2M | +0.01% |
| Q1 2020 | 11.0K | $927,000 | +0.01% |
| Q4 2019 | 14.9K | $1M | +0.01% |
| Q1 2019 | 12.7K | $1M | +0.01% |
| Q4 2018 | 13.5K | $1M | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of BMRN.